To edit or not to edit

Regulation of ADAR editing specificity and efficiency

Sarah N. Deffit, Heather Hundley

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Hundreds to millions of adenosine (A)-to-inosine (I) modifications are present in eukaryotic transcriptomes and play an essential role in the creation of proteomic and phenotypic diversity. As adenosine and inosine have different base-pairing properties, the functional consequences of these modifications or 'edits' include altering coding potential, splicing, and miRNA-mediated gene silencing of transcripts. However, rather than serving as a static control of gene expression, A-to-I editing provides a means to dynamically rewire the genetic code during development and in a cell-type specific manner. Interestingly, during normal development, in specific cells, and in both neuropathological diseases and cancers, the extent of RNA editing does not directly correlate with levels of the substrate mRNA or the adenosine deaminase that act on RNA (ADAR) editing enzymes, implying that cellular factors are required for spatiotemporal regulation of A-to-I editing. The factors that affect the specificity and extent of ADAR activity have been thoroughly dissected in vitro. Yet, we still lack a complete understanding of how specific ADAR family members can selectively deaminate certain adenosines while others cannot. Additionally, in the cellular environment, ADAR specificity and editing efficiency is likely to be influenced by cellular factors, which is currently an area of intense investigation. Data from many groups have suggested two main mechanisms for controlling A-to-I editing in the cell: (1) regulating ADAR accessibility to target RNAs and (2) protein-protein interactions that directly alter ADAR enzymatic activity. Recent studies suggest cis- and trans-acting RNA elements, heterodimerization and RNA-binding proteins play important roles in regulating RNA editing levels in vivo.

Original languageEnglish (US)
Pages (from-to)113-127
Number of pages15
JournalWiley Interdisciplinary Reviews: RNA
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

RNA Editing
Adenosine Deaminase
RNA
Adenosine
Inosine
Genetic Code
RNA-Binding Proteins
Gene Silencing
MicroRNAs
Transcriptome
Base Pairing
Proteomics
Proteins
Gene Expression
Messenger RNA
Gene expression
Enzymes
Genes
Neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

To edit or not to edit : Regulation of ADAR editing specificity and efficiency. / Deffit, Sarah N.; Hundley, Heather.

In: Wiley Interdisciplinary Reviews: RNA, Vol. 7, No. 1, 01.01.2016, p. 113-127.

Research output: Contribution to journalArticle

Deffit, Sarah N. ; Hundley, Heather. / To edit or not to edit : Regulation of ADAR editing specificity and efficiency. In: Wiley Interdisciplinary Reviews: RNA. 2016 ; Vol. 7, No. 1. pp. 113-127.
@article{2a3cafbf4e9245cb951822687280cbab,
title = "To edit or not to edit: Regulation of ADAR editing specificity and efficiency",
abstract = "Hundreds to millions of adenosine (A)-to-inosine (I) modifications are present in eukaryotic transcriptomes and play an essential role in the creation of proteomic and phenotypic diversity. As adenosine and inosine have different base-pairing properties, the functional consequences of these modifications or 'edits' include altering coding potential, splicing, and miRNA-mediated gene silencing of transcripts. However, rather than serving as a static control of gene expression, A-to-I editing provides a means to dynamically rewire the genetic code during development and in a cell-type specific manner. Interestingly, during normal development, in specific cells, and in both neuropathological diseases and cancers, the extent of RNA editing does not directly correlate with levels of the substrate mRNA or the adenosine deaminase that act on RNA (ADAR) editing enzymes, implying that cellular factors are required for spatiotemporal regulation of A-to-I editing. The factors that affect the specificity and extent of ADAR activity have been thoroughly dissected in vitro. Yet, we still lack a complete understanding of how specific ADAR family members can selectively deaminate certain adenosines while others cannot. Additionally, in the cellular environment, ADAR specificity and editing efficiency is likely to be influenced by cellular factors, which is currently an area of intense investigation. Data from many groups have suggested two main mechanisms for controlling A-to-I editing in the cell: (1) regulating ADAR accessibility to target RNAs and (2) protein-protein interactions that directly alter ADAR enzymatic activity. Recent studies suggest cis- and trans-acting RNA elements, heterodimerization and RNA-binding proteins play important roles in regulating RNA editing levels in vivo.",
author = "Deffit, {Sarah N.} and Heather Hundley",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/wrna.1319",
language = "English (US)",
volume = "7",
pages = "113--127",
journal = "Wiley interdisciplinary reviews. RNA",
issn = "1757-7004",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - To edit or not to edit

T2 - Regulation of ADAR editing specificity and efficiency

AU - Deffit, Sarah N.

AU - Hundley, Heather

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Hundreds to millions of adenosine (A)-to-inosine (I) modifications are present in eukaryotic transcriptomes and play an essential role in the creation of proteomic and phenotypic diversity. As adenosine and inosine have different base-pairing properties, the functional consequences of these modifications or 'edits' include altering coding potential, splicing, and miRNA-mediated gene silencing of transcripts. However, rather than serving as a static control of gene expression, A-to-I editing provides a means to dynamically rewire the genetic code during development and in a cell-type specific manner. Interestingly, during normal development, in specific cells, and in both neuropathological diseases and cancers, the extent of RNA editing does not directly correlate with levels of the substrate mRNA or the adenosine deaminase that act on RNA (ADAR) editing enzymes, implying that cellular factors are required for spatiotemporal regulation of A-to-I editing. The factors that affect the specificity and extent of ADAR activity have been thoroughly dissected in vitro. Yet, we still lack a complete understanding of how specific ADAR family members can selectively deaminate certain adenosines while others cannot. Additionally, in the cellular environment, ADAR specificity and editing efficiency is likely to be influenced by cellular factors, which is currently an area of intense investigation. Data from many groups have suggested two main mechanisms for controlling A-to-I editing in the cell: (1) regulating ADAR accessibility to target RNAs and (2) protein-protein interactions that directly alter ADAR enzymatic activity. Recent studies suggest cis- and trans-acting RNA elements, heterodimerization and RNA-binding proteins play important roles in regulating RNA editing levels in vivo.

AB - Hundreds to millions of adenosine (A)-to-inosine (I) modifications are present in eukaryotic transcriptomes and play an essential role in the creation of proteomic and phenotypic diversity. As adenosine and inosine have different base-pairing properties, the functional consequences of these modifications or 'edits' include altering coding potential, splicing, and miRNA-mediated gene silencing of transcripts. However, rather than serving as a static control of gene expression, A-to-I editing provides a means to dynamically rewire the genetic code during development and in a cell-type specific manner. Interestingly, during normal development, in specific cells, and in both neuropathological diseases and cancers, the extent of RNA editing does not directly correlate with levels of the substrate mRNA or the adenosine deaminase that act on RNA (ADAR) editing enzymes, implying that cellular factors are required for spatiotemporal regulation of A-to-I editing. The factors that affect the specificity and extent of ADAR activity have been thoroughly dissected in vitro. Yet, we still lack a complete understanding of how specific ADAR family members can selectively deaminate certain adenosines while others cannot. Additionally, in the cellular environment, ADAR specificity and editing efficiency is likely to be influenced by cellular factors, which is currently an area of intense investigation. Data from many groups have suggested two main mechanisms for controlling A-to-I editing in the cell: (1) regulating ADAR accessibility to target RNAs and (2) protein-protein interactions that directly alter ADAR enzymatic activity. Recent studies suggest cis- and trans-acting RNA elements, heterodimerization and RNA-binding proteins play important roles in regulating RNA editing levels in vivo.

UR - http://www.scopus.com/inward/record.url?scp=84955464451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955464451&partnerID=8YFLogxK

U2 - 10.1002/wrna.1319

DO - 10.1002/wrna.1319

M3 - Article

VL - 7

SP - 113

EP - 127

JO - Wiley interdisciplinary reviews. RNA

JF - Wiley interdisciplinary reviews. RNA

SN - 1757-7004

IS - 1

ER -